Inventor · disambiguated record
Andrew Nixon
Also filed as: NIXON ANDREW · NIXON ANDREW E
22 granted patents·15 pending applications·177 citations·filing 2000–2025
95Inventor score
Files withTAKEDA PHARMACEUTICALS CO13DYAX CORP11ATHERA BIOTECHNOLOGIES AB4DYAX CORP A MASSACHUSETTS CORP2PENN STATE RES FOUND2
Top patents by PatentIndex Score
37 records- 0195US12110343B2Anti-plasma kallikrein antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Oct 8, 2024·4 cites·10 claims
- 0295US12084515B2Compositions and methods for treatment of diabetic macular edemaTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Sep 10, 2024·4 cites·10 claims
- 0395US11046785B2Compositions and methods for treatment of diabetic macular edemaDYAX CORP·Filed 2019·Granted Jun 29, 2021·11 cites·7 claims
- 0495US10648990B2Diagnosis and treatment of autoimmune diseasesDYAX CORP·Filed 2018·Granted May 12, 2020·7 cites·10 claims
- 0594US12061206B2Diagnosis and treatment of autoimmune diseasesTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Aug 13, 2024·3 cites·13 claims
- 0694US7329737B2Antibodies that bind hK-1DYAX CORP·Filed 2005·Granted Feb 12, 2008·54 cites·17 claims
- 0792US11299553B2Anti-plasma kallikrein antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 12, 2022·8 cites·16 claims
- 0892US10428158B2Compositions and methods for treatment of diabetic macular edemaDYAX CORP·Filed 2015·Granted Oct 1, 2019·14 cites·9 claims
- 0990US11372002B2Assays for determining plasma kallikrein system biomarkersTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Jun 28, 2022·9 cites·15 claims
- 1087US11156612B2Methods of determining levels of cleaved and/or intact kininogenTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Oct 26, 2021·6 cites·15 claims
- 1187US10101344B2Diagnosis and treatment of autoimmune diseasesDYAX CORP·Filed 2014·Granted Oct 16, 2018·8 cites·18 claims
- 1287US7993646B2HK1-binding proteinsDYAX CORP·Filed 2007·Granted Aug 9, 2011·11 cites·27 claims
- 1387US7820413B2Incrementally truncated nucleic acids and methods of making samePENN STATE RES FOUND·Filed 2008·Granted Oct 26, 2010·8 cites·9 claims
- 1484US2025129182A1Anti-plasma kallikrein antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 1582US7273610B2Endotheliase-2 ligandsDYAX CORP·Filed 2004·Granted Sep 25, 2007·14 cites·13 claims
- 1680US10913802B2Monoclonal antibody inhibitor of factor XIIADYAX CORP·Filed 2016·Granted Feb 9, 2021·3 cites·15 claims
- 1779US11390687B2Bispecific antibodies against plasma kallikrein and Factor XIITAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jul 19, 2022·3 cites·26 claims
- 1878US7332308B1Incrementally truncated nucleic acids and methods of making samePENN STATE RES FOUND·Filed 2000·Granted Feb 19, 2008·5 cites·10 claims
- 1975US12442824B2Assays for determining plasma kallikrein system biomarkersTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Oct 14, 2025·0 cites·9 claims
- 2074US9803028B2Antibodies against phosphorylcholinePETTERSSON KNUT·Filed 2012·Granted Oct 31, 2017·3 cites·19 claims
- 2171US9796786B2Antibodies binding to phosphorylcholine (PC) and/or PC conjugatesPETTERSSON KNUT·Filed 2012·Granted Oct 24, 2017·2 cites·19 claims
- 2266US12240918B2Bispecific antibodies against plasma kallikrein and factor XIITAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Mar 4, 2025·0 cites·16 claims
- 2364US12415866B2Monoclonal antibody inhibitor of Factor XIIaTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Sep 16, 2025·0 cites·13 claims
- 2464US2021230310A1Antibodies binding to phosphorylcholine (pc) and/or pc conjugatesATHERA BIOTECHNOLOGIES AB·Filed 2021·Application pending·0 cites
- 2564US2021238311A1Antibodies against phosphorylcholineATHERA BIOTECHNOLOGIES AB·Filed 2021·Application pending·0 cites
- 2664US2022170936A1Evaluation and treatment of bradykinin-mediated disordersTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 2759US2016017055A1Anti-plasma kallikrein antibodiesDYAX CORP·Filed 2014·Application pending·0 cites
- 2858US2008075723A1Endotheliase 2 ligandsDYAX CORP A MASSACHUSETTS CORP·Filed 2007·Application pending·0 cites
- 2958US2008019962A1Endotheliase-2 ligandsDYAX CORP A MASSACHUSETTS CORP·Filed 2007·Application pending·0 cites
- 3057US2004209243A1Kunitz domain libraryNIXON ANDREW·Filed 2004·Application pending·0 cites
- 3156US2008020394A1Kunitz Domain LibraryDYAX CORP·Filed 2007·Application pending·0 cites
- 3255US2005164945A1Endotheliase-1 ligandsFiled 2004·Application pending·0 cites
- 3350US2018086847A1Antibodies binding to phosphorylcholine (pc) and/or pc conjugatesATHERA BIOTECHNOLOGIES AB·Filed 2017·Application pending·0 cites
- 3450US2018086848A1Antibodies against phosphorylcholineATHERA BIOTECHNOLOGIES AB·Filed 2017·Application pending·0 cites
- 3549US2012027686A1Hk1-binding proteinsSEXTON DANIEL J·Filed 2011·Application pending·0 cites
- 3649US2005009136A1PAPP-A ligandsDYAX CORP·Filed 2004·Application pending·0 cites
- 3744US2025263504A1Bispecific antibodies against plasma kallikrein and factor xiiTAKEDA PHARMACEUTICALS CO·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Nixon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →